Cardiff Oncology, Inc.CRDFNASDAQ
LOADING
|||
EPS Growth Recovery in Progress
Trending higher, below historical average, structural decline.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-2.15%
↓ 111% below average
Average (9y)
19.44%
Historical baseline
Range
High:86.35%
Low:-38.36%
CAGR
-27.4%
Structural decline
| Period | Value |
|---|---|
| 2024 | -2.15% |
| 2023 | -4.49% |
| 2022 | -21.92% |
| 2021 | 32.41% |
| 2020 | 60.00% |
| 2019 | 61.76% |
| 2018 | 86.35% |
| 2017 | 44.72% |
| 2016 | -23.91% |
| 2015 | -38.36% |